| Literature DB >> 31861298 |
Xin Xie1,2, Sushila Maharjan2,3, Sanwei Liu4, Yu Shrike Zhang2, Carol Livermore1.
Abstract
Modular microfluidics offer the opportunity to combine the precise fluid control, rapid sample processing, low sample and reagent volumes, and relatively lower cost of conventional microfluidics with the flexible reconfigurability needed to accommodate the requirements of target applications such as drug toxicity studies. However, combining the capabilities of fully adaptable modular microelectromechanical systems (MEMS) assembly with the simplicity of conventional microfluidic fabrication remains a challenge. A hybrid polydimethylsiloxane (PDMS)-molding/photolithographic process is demonstrated to rapidly fabricate LEGO®-like modular blocks. The blocks are created with different sizes that interlock via tongue-and-groove joints in the plane and stack via interference fits out of the plane. These miniature strong but reversible connections have a measured resistance to in-plane and out-of-plane forces of up to >6000× and >1000× the weight of the block itself, respectively. The LEGO®-like interference fits enable O-ring-free microfluidic connections that withstand internal fluid pressures of >120 kPa. A single layer of blocks is assembled into LEGO®-like cell culture plates, where the in vitro biocompatibility and drug toxicity to lung epithelial adenocarcinoma cells and hepatocellular carcinoma cells cultured in the modular microwells are measured. A double-layer block structure is then assembled so that a microchannel formed at the interface between layers connects two microwells. Breast tumor cells and hepatocytes cultured in the coupled wells demonstrate interwell migration as well as the simultaneous effects of a single drug on the two cell types.Entities:
Keywords: cell culture; drug toxicity assay; microphysiological system; modular microassembly; modular microfluidics
Year: 2019 PMID: 31861298 PMCID: PMC7020019 DOI: 10.3390/mi11010002
Source DB: PubMed Journal: Micromachines (Basel) ISSN: 2072-666X Impact factor: 2.891
Figure 1Fabrication and assembly of the micro building blocks. (1). Sequence of steps in the fabrication of micro building block elements. (2). Schematic diagrams of an exploded view of a micro building block. The male and female connectors are nominally 530 µm and 460 µm across, respectively. (3). Schematic diagrams of micro building blocks with different lengths and an assembled pyramid.
Figure 2Diagrams of microfluidic testing and of coupled microwell testing. (1). For microfluidic testing, tubing is attached on either side of two micro building blocks (a); the two micro blocks are pressed together via their interference fits to form an O-ring-free sealed microfluidic system (b); and the microfluidic system is tested under pressure from the inlet with a closed outlet (c). (2). For testing of coupled microwells, a micro block with through holes is pressed to a micro block with a grooved surface to create an enclosed microfluidic channel that couples two microwells from beneath; the color gradient is a schematic representation of mass transport.
Figure 3Micrographs and photographs of micro building blocks. (1). Optical micrographs of the three elements with footprint dimensions (from left to right) of 1 × 1 mm2, 2 × 1 mm2, and 3 × 1 mm2; all three micrographs have the same scale bar. (2). Plot of measured force vs. displacement for two 3 × 1 elements connected via an interlocking in-plane connection (a). Photographs of a demonstration structure created by micro building block elements on a US quarter (b) and a 4.2 g bolt hanging from the inverted demonstration structure. The weight of the bolt is supported solely by the interference fits (nine of them at the narrowest point) (c). (3). Photographs of the O-ring-free microfluidic interface testing (a), and photographs of the top (b) and angled (c) view of the assembled microwell chips filled with red- and green-colored liquids.
Figure 4Application of microwell arrays in cell culture and drug testing. (1). Viability of A549 cells within modular microwell arrays on day 4 showing (a) the live (green) and dead (red) cells, and (b) F-actin (red) and nuclei (blue) staining of the cells on day 5. (2). Viability of HepG2 cells within modular microwell arrays on day 4 showing (a) the live (green) and dead (red) cells, and (b) F-actin (red) and nuclei (blue) staining of the cells on day 5. (3). Quantitative metabolic activity of HepG2 cells as determined by the 3-(4,5-dimethylthiazol-2-yl)- MTS assay after treatment with indicated doses of APAP after 12 h of exposure. The asterisk represents statistically significant differences (p < 0.05).
Figure 5Results of coupled microwell experiments. 1. Schematic showing co-culture of 4T1 cells and HepG2-C3A cells in two microwells that are coupled by an underlying microfluidic channel. 2. Fluorescence micrographs showing cell migration after 6 days of culture. 3. Viability of HepG2-C3A and 4T1 cells in coupled microwells after APAP treatment showing the live (green) and dead (red) cells. 4. Quantitative metabolic activity of the cells measured using the MTS assay after treatment with indicated doses of APAP. The asterisks represent statistically significant differences (p < 0.05).